Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development
ANGEL Brings Professional Coffee Water Solutions to the 2026 San Francisco Coffee Festival
Pasithea Therapeutics Presents Positive Initial Phase 1/1b Data for PAS-004, Showing Substantial Reductions in Cutaneous Neurofibroma Size and Early Activity in Plexiform Neurofibromas at the 2026 European Neurofibromatosis Conference
Bavarian Nordic Launches Next Tranche of DKK 750 Million Share Buy-Back Program
Bavarian Nordic Reports Strong Travel Health Growth in the Third Quarter and Confirms Solid Momentum for the Rest of the Year
Innovative XCART platform with demonstrated proof of mechanism and preclinical evidence of target specificity positions Xenetic to address high value...
AUSTIN, TX / ACCESSWIRE / March 4, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, announced today...
The Company qualifies for reduced or waived fees for medical device submissions with the FDA HOUSTON, TX / ACCESSWIRE /...
TORONTO, ONTRAIO / ACCESSWIRE / March 4, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
TORONTO, ON / ACCESSWIRE / March 4, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellipharmaceutics" or the "Company"),...
REDWOOD CITY, CA / ACCESSWIRE / March 1, 2019 / Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments...
WALTHAM, MA / ACCESSWIRE / March 1, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (''EyeGate'' or ''the Company'') today announced...
TORONTO, ON / ACCESSWIRE / February 27, 2019 / Itoco Inc (OTC PINK: ITMC), has signed a letter of intent...
- Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment after tumor progression on prior...
Uses proprietary chemoprobe technology to demonstrate target engagement, key to drug development and rational dosing Useful to identify interaction partners...
PHASE II CLINICAL TRIAL ON PERSISTENT CHRONIC COUGH HAMBURG, GERMANY / ACCESSWIRE / February 28, 2019 / Evotec AG (OTC...
Theralase Achieves Third Place in the Clean Technology and Life Sciences Category on the 2019 TSX Venture 50 TM TORONTO,...
VANCOUVER, BC / ACCESSWIRE / February 28, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the ''Company'') provides...
DALLAS, TX / ACCESSWIRE / February 26, 2019 / What if there was a way to prioritize drug discovery by...
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / February 27, 2019 / MorphoSys AG (FSE: MOR) (NASDAQ: MOR) announced today that...
Data identifies a simple blood test that predicts clinical response to pelareorep CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE...
CHINO HILLS, CA / ACCESSWIRE / February 26, 2019 / SOHM, Inc. (OTC PINK: SHMN), a generic Pharmaceutical, Nutraceutical, and...
James Strole and Bernadeane of People Unlimited, Inc. have dedicated their lives to building a community for ageless prosperity. This...
VANCOUVER, BC / ACCESSWIRE / February 25, 2019 / Eviana Health Corporation ("Eviana". the "Company") (CSE: EHC) (OTC: EVNNF) is...
CALGARY, AB / ACCESSWIRE / February 26, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
